Who measures the Holy Dread?

BMJ 2005; 331 doi: (Published 30 June 2005) Cite this as: BMJ 2005;331:57
  1. Kevin Barraclough, general practitioner
  1. Painswick, Gloucestershire

    If you tell patients that a drug is shown in a trial to reduce their absolute risk by 0.2% per year they usually don't want it. They weigh the marginal absolute benefit against the harm of being “medicalised,” and they decline. The opinion forming “experts” who ran the trial take a different view. The experts demonstrate the relative risk reduction with bar charts at a string of lucrative international conferences. They sit on the guidelines …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription